[10-Q] Smurfit Westrock plc Quarterly Earnings Report
Smurfit Westrock plc reported Q3 2025 results reflecting post‑merger scale and ongoing integration. Net sales were $8,003 million, operating profit $526 million, and net income $246 million, or diluted EPS of $0.47. This compares with Q3 2024 net sales of $7,671 million and a net loss of $150 million.
For the first nine months of 2025, net sales were $23,599 million with operating profit of $1,330 million and net income of $602 million. Cash from operations reached $2,197 million, funding capital expenditures of $1,609 million and cash dividends of $675 million.
The balance sheet shows total assets of $45,569 million, cash and cash equivalents of $851 million, total debt of $14,111 million (including $798 million current), and shareholders’ equity of $18,433 million. Q3 included $65 million of impairment and $7 million of restructuring costs; year‑to‑date these totaled $360 million and $118 million, respectively, tied in part to facility closures announced in April 2025. The company expects $39 million of additional closure‑related charges through 2026. As of October 31, 2025, shares outstanding were 522,186,327.
- None.
- None.
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification Number) |
N/A | ||
(Address of principal executive offices) | (Zip Code) |
Title of Each Class | Trading Symbol(s) | Name of Each Exchange on Which Registered | ||
Large accelerated filer | ☐ | Accelerated filer | ☐ |
☒ | Smaller reporting company | ||
Emerging growth company | |||
Page | |
EXPLANATORY NOTE | 3 |
PART I - FINANCIAL INFORMATION | 6 |
Item 1. Financial Statements | 6 |
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations | 37 |
Item 3. Quantitative and Qualitative Disclosures About Market Risk | 51 |
Item 4. Controls and Procedures | 51 |
PART II - OTHER INFORMATION | 53 |
Item 1. Legal Proceedings | 53 |
Item 1A. Risk Factors | 53 |
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds | 53 |
Item 3. Defaults Upon Senior Securities | 53 |
Item 4. Mine Safety Disclosures | 53 |
Item 5. Other Information | 53 |
Item 6. Exhibits | 54 |
Signatures | 55 |
Page | |
Condensed Consolidated Balance Sheets as of September 30, 2025 and December 31, 2024 | 7 |
Condensed Consolidated Statements of Operations for the three and nine months ended September 30, 2025 and September 30, 2024 | 8 |
Condensed Consolidated Statements of Comprehensive Income (Loss) for the three and nine months ended September 30, 2025 and September 30, 2024 | 9 |
Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2025 and September 30, 2024 | 10 |
Condensed Consolidated Statements of Changes in Equity for the three and nine months ended September 30, 2025 and September 30, 2024 | 11 |
Notes to Condensed Consolidated Financial Statements | 14 |
September 30, 2025 | December 31, 2024 | ||
Assets | |||
Current assets: | |||
Cash and cash equivalents (amounts related to consolidated variable interest entities of $ $ | $ | $ | |
Accounts receivable, net (amounts related to consolidated variable interest entities of $ $ | |||
Inventories | |||
Other current assets | |||
Total current assets | |||
Property, plant and equipment, net | |||
Goodwill | |||
Intangibles, net | |||
Prepaid pension asset | |||
Other non-current assets (amounts related to consolidated variable interest entities of $ $ | |||
Total assets | $ | $ | |
Liabilities and Equity | |||
Current liabilities: | |||
Accounts payable | $ | $ | |
Accrued compensation and benefits | |||
Current portion of debt | |||
Other current liabilities | |||
Total current liabilities | |||
Non-current debt due after one year (amounts related to consolidated variable interest entities of $ million and $ | |||
Deferred tax liabilities | |||
Pension liabilities and other postretirement benefits, net of current portion | |||
Other non-current liabilities (amounts related to consolidated variable interest entities of $ and $ | |||
Total liabilities | |||
Commitments and Contingencies (Note 16) | |||
Equity: | |||
Preferred stock; $ | |||
Common stock; $ shares outstanding at September 30, 2025 and December 31, 2024, respectively | |||
Deferred shares; € September 30, 2025 and December 31, 2024, respectively | |||
Treasury stock; at cost; December 31, 2024, respectively | ( | ( | |
Capital in excess of par value | |||
Accumulated other comprehensive loss | ( | ( | |
Retained earnings | |||
Total shareholders’ equity | |||
Noncontrolling interests | |||
Total equity | |||
Total liabilities and equity | $ | $ |
Three months ended September 30, | Nine months ended September 30, | ||||||
2025 | 2024 | 2025 | 2024 | ||||
Net sales | $ | $ | $ | $ | |||
Cost of goods sold | ( | ( | ( | ( | |||
Gross profit | |||||||
Selling, general and administrative expenses | ( | ( | ( | ( | |||
Impairment and restructuring costs | ( | ( | ( | ( | |||
Transaction and integration-related expenses associated with the Combination | ( | ( | ( | ( | |||
Operating profit | |||||||
Pension and other postretirement non-service income (expense), net | ( | ||||||
Interest expense, net | ( | ( | ( | ( | |||
Other expense, net | ( | ( | ( | ( | |||
Income (loss) before income taxes | ( | ||||||
Income tax expense | ( | ( | ( | ( | |||
Net income (loss) | ( | ||||||
Net loss attributable to noncontrolling interests | |||||||
Net income (loss) attributable to common shareholders | $ | $( | $ | $ | |||
Basic earnings (loss) per share attributable to common shareholders | $ | $( | $ | $ | |||
Diluted earnings (loss) per share attributable to common shareholders | $ | $( | $ | $ | |||
The accompanying notes are an integral part of these Unaudited Condensed Consolidated Financial Statements. | |||||||
Three months ended September 30, | Nine months ended September 30, | ||||||
2025 | 2024 | 2025 | 2024 | ||||
Net income (loss) | $ | $( | $ | $ | |||
Other comprehensive income (loss), net of tax: | |||||||
Foreign currency translation gain (loss) | ( | ||||||
Defined benefit pension and other postretirement benefit plans adjustments | ( | ( | |||||
Net gain (loss) on cash flow hedges | ( | ||||||
Other comprehensive income (loss), net of tax | ( | ||||||
Comprehensive income (loss) | ( | ||||||
Comprehensive loss attributable to noncontrolling interests | |||||||
Comprehensive income (loss) attributable to common shareholders | $ | $( | $ | $ | |||
The accompanying notes are an integral part of these Unaudited Condensed Consolidated Financial Statements. | |||||||
Nine months ended September 30, | |||
2025 | 2024 | ||
Operating activities: | |||
Net income | $ | $ | |
Adjustments to reconcile consolidated net income to net cash provided by operating activities: | |||
Depreciation, depletion and amortization | |||
Impairment charges | |||
Cash surrender value increase in excess of premiums paid | ( | ( | |
Share-based compensation expense | |||
Deferred income tax benefit | ( | ( | |
Pension and other postretirement funding more than cost | ( | ( | |
Other | |||
Change in operating assets and liabilities, net of acquisitions and divestitures: | |||
Accounts receivable | ( | ( | |
Inventories | ( | ||
Other assets | ( | ( | |
Accounts payable | ( | ( | |
Income taxes | |||
Accrued liabilities and other | |||
Net cash provided by operating activities | |||
Investing activities: | |||
Capital expenditures | ( | ( | |
Cash paid for purchase of businesses, net of cash acquired | ( | ( | |
Proceeds from corporate owned life insurance | |||
Proceeds from sale of property, plant and equipment | |||
Other | |||
Net cash used for investing activities | ( | ( | |
Financing activities: | |||
Additions to debt | |||
Repayments of debt | ( | ( | |
Debt issuance costs | ( | ( | |
Changes in commercial paper, net | ( | ( | |
Other debt (repayments) additions, net | ( | ||
Repayments of finance lease liabilities | ( | ( | |
Tax paid in connection with shares withheld from employees | ( | ( | |
Purchases of treasury stock | ( | ||
Cash dividends paid to shareholders | ( | ( | |
Other | ( | ||
Net cash (used for) provided by financing activities | ( | ||
Effect of exchange rate changes on cash and cash equivalents | ( | ||
Decrease in cash and cash equivalents | ( | ( | |
Cash and cash equivalents at beginning of period | |||
Cash and cash equivalents at end of period | $ | $ | |
Shares of Common Stock | Common Stock | Capital in Excess of Par Value | Treasury Stock | Retained Earnings | Accumulated Other Comprehensive Loss | Total Shareholders' Equity | Noncontrolling Interest ("NCI") | Total | |
Balance at June 30, 2025 | $ | $ | $( | $ | $( | $ | $ | $ | |
Net income (loss) | — | — | — | — | — | ( | |||
Other comprehensive income, net of tax | — | — | — | — | — | — | |||
Share-based compensation | — | — | — | — | — | — | |||
Issuance of common stock net of tax paid in connection with shares withheld from employees | — | — | — | ( | — | — | |||
Dividends declared ($ | — | — | — | ( | — | ( | — | ( | |
Balance at September 30, 2025 | $ | $ | $( | $ | $( | $ | $ | $ |
Shares of Common Stock | Common Stock | Capital in Excess of Par Value | Treasury Stock | Retained Earnings | Accumulated Other Comprehensive Loss | Total Shareholders' Equity | Noncontrolling Interest | Total | |
Balance at June 30, 2024(1) | $ | $ | $( | $ | $( | $ | $ | $ | |
Net loss | — | — | — | — | ( | — | ( | — | ( |
Other comprehensive income, net of tax | — | — | — | — | — | — | |||
Share-based compensation | — | — | — | — | — | — | |||
Shares of Smurfit Westrock common stock issued to WestRock shareholders and NCI assumed as a result of the Merger | — | — | — | ||||||
Converted WestRock restricted stock units and stock options attributable to pre-Combination services | — | — | — | — | — | — | |||
Issuance of common stock net of tax paid in connection with shares withheld from employees | — | — | — | ( | — | ( | — | ( | |
Dividends declared ($ | — | — | — | ( | — | ( | — | ( | |
Balance at September 30, 2024 | $ | $ | $( | $ | $( | $ | $ | $ |
Shares of Common Stock | Common Stock | Capital in Excess of Par Value | Treasury Stock | Retained Earnings | Accumulated Other Comprehensive Loss | Total Shareholders' Equity | Noncontrolling Interest | Total | |
Balance at December 31, 2024 | $ | $ | $( | $ | $( | $ | $ | $ | |
Net income (loss) | — | — | — | — | — | ( | |||
Other comprehensive income, net of tax | — | — | — | — | — | — | |||
Share-based compensation | — | — | — | — | — | — | |||
Shares distributed by Smurfit Kappa Employee Trust | — | — | ( | — | — | — | |||
Issuance of common stock net of tax paid in connection with shares withheld from employees | — | — | ( | — | ( | — | ( | ||
Cancellation of deferred shares by Smurfit Kappa Employee Trust | — | — | — | ( | — | — | |||
Dividends declared ($ | — | — | — | ( | — | ( | — | ( | |
Balance at September 30, 2025 | $ | $ | $( | $ | $( | $ | $ | $ |
Shares of Common Stock | Common Stock | Capital in Excess of Par Value | Treasury Stock | Retained Earnings | Accumulated Other Comprehensive Loss | Total Shareholders' Equity | Noncontrolling Interest | Total | |
Balance at December 31, 2023(1) | $ | $ | $( | $ | $( | $ | $ | $ | |
Net income | — | — | — | — | — | — | |||
Other comprehensive loss, net of tax | — | — | — | — | — | ( | ( | — | ( |
Share-based compensation | — | — | — | — | — | — | |||
Shares distributed by Smurfit Kappa Employee Trust | — | — | ( | — | — | — | |||
Purchases of treasury stock | — | — | — | ( | — | — | ( | — | ( |
Shares of Smurfit Westrock common stock issued to WestRock shareholders and NCI assumed as a result of the Merger | — | — | — | ||||||
Converted WestRock restricted stock units and stock options attributable to pre-Combination services | — | — | — | — | — | — | |||
Issuance of common stock net of tax paid in connection with shares withheld from employees | — | — | — | ( | — | ( | — | ( | |
Dividends declared ($ | — | — | — | ( | — | ( | — | ( | |
Balance at September 30, 2024 | $ | $ | $( | $ | $( | $ | $ | $ |
Three months ended | Nine months ended | ||
September 30, 2024 | September 30, 2024 | ||
Net sales | $ | $ | |
Net income attributable to common shareholders |
Three months ended September 30, 2025 | North America | Europe, MEA and APAC | LATAM | Total | |||
Net sales (unaffiliated customers) | $ | $ | $ | $ | |||
Add net sales (intersegment) | |||||||
Net sales (aggregate) | |||||||
Less segment expenses: | |||||||
Segment cost of goods sold | ( | ( | ( | ||||
Segment selling, general and administrative expenses | ( | ( | ( | ||||
( | ( | ( | ( | ||||
Segment Adjusted EBITDA | $ | $ | $ | $ | |||
Unallocated corporate costs | ( | ||||||
Depreciation, depletion and amortization | ( | ||||||
Impairment and restructuring costs | ( | ||||||
Transaction and integration-related expenses associated with the Combination | ( | ||||||
Interest expense, net | ( | ||||||
Pension and other postretirement non-service income, net | |||||||
Share-based compensation expense | ( | ||||||
Other expense, net | ( | ||||||
Other adjustments | ( | ||||||
Income before income taxes | $ |
Three months ended September 30, 2024 | North America | Europe, MEA and APAC | LATAM | Total | |||
Net sales (unaffiliated customers) | $ | $ | $ | $ | |||
Add net sales (intersegment) | |||||||
Net sales (aggregate) | |||||||
Less segment expenses: | |||||||
Segment cost of goods sold | ( | ( | ( | ||||
Segment selling, general and administrative expenses | ( | ( | ( | ||||
( | ( | ( | ( | ||||
Segment Adjusted EBITDA | $ | $ | $ | $ | |||
Unallocated corporate costs | ( | ||||||
Depreciation, depletion and amortization | ( | ||||||
Impairment and restructuring costs | ( | ||||||
Transaction and integration-related expenses associated with the Combination | ( | ||||||
Amortization of fair value step up on inventory | ( | ||||||
Interest expense, net | ( | ||||||
Pension and other postretirement non-service income, net | |||||||
Share-based compensation expense | ( | ||||||
Other expense, net | ( | ||||||
Other adjustments | ( | ||||||
Loss before income taxes | $( |
Nine months ended September 30, 2025 | North America | Europe, MEA and APAC | LATAM | Total | |||
Net sales (unaffiliated customers) | $ | $ | $ | $ | |||
Add net sales (intersegment) | |||||||
Net sales (aggregate) | |||||||
Less segment expenses: | |||||||
Segment cost of goods sold | ( | ( | ( | ||||
Segment selling, general and administrative expenses | ( | ( | ( | ||||
( | ( | ( | ( | ||||
Segment Adjusted EBITDA | $ | $ | $ | $ | |||
Unallocated corporate costs | ( | ||||||
Depreciation, depletion and amortization | ( | ||||||
Impairment and restructuring costs | ( | ||||||
Transaction and integration-related expenses associated with the Combination | ( | ||||||
Interest expense, net | ( | ||||||
Pension and other postretirement non-service income, net | |||||||
Share-based compensation expense | ( | ||||||
Other expense, net | ( | ||||||
Other adjustments | ( | ||||||
Income before income taxes | $ |
Nine months ended September 30, 2024 | North America | Europe, MEA and APAC | LATAM | Total | |||
Net sales (unaffiliated customers) | $ | $ | $ | $ | |||
Add net sales (intersegment) | |||||||
Net sales (aggregate) | |||||||
Less segment expenses: | |||||||
Segment cost of goods sold | ( | ( | ( | ||||
Segment selling, general and administrative expenses | ( | ( | ( | ||||
( | ( | ( | ( | ||||
Segment Adjusted EBITDA | $ | $ | $ | $ | |||
Unallocated corporate costs | ( | ||||||
Depreciation, depletion and amortization | ( | ||||||
Impairment and restructuring costs | ( | ||||||
Transaction and integration-related expenses associated with the Combination | ( | ||||||
Amortization of fair value step up on inventory | ( | ||||||
Interest expense, net | ( | ||||||
Pension and other postretirement non-service expense, net | ( | ||||||
Share-based compensation expense | ( | ||||||
Other expense, net | ( | ||||||
Other adjustments | |||||||
Income before income taxes | $ |
Nine months ended September 30, | |||
2025 | 2024 | ||
Capital expenditures: | |||
North America | $ | $ | |
Europe, MEA and APAC | |||
LATAM | |||
Total reportable segments | |||
Corporate | |||
Total capital expenditures | $ | $ | |
September 30, | December 31, | ||
2025 | 2024 | ||
Assets: | |||
North America | $ | $ | |
Europe, MEA and APAC | |||
LATAM | |||
Total reportable segments | |||
Corporate(1) | |||
Total assets | $ | $ |
Three months ended September 30, 2025 | |||||||
North America | Europe, MEA and APAC | LATAM | Total | ||||
Revenue by product: | |||||||
Paper | $ | $ | $ | $ | |||
Packaging | |||||||
Total | $ | $ | $ | $ | |||
Three months ended September 30, 2024 | |||||||
North America | Europe, MEA and APAC | LATAM | Total | ||||
Revenue by product: | |||||||
Paper | $ | $ | $ | $ | |||
Packaging | |||||||
Total | $ | $ | $ | $ | |||
Nine months ended September 30, 2025 | |||||||
North America | Europe, MEA and APAC | LATAM | Total | ||||
Revenue by product: | |||||||
Paper | $ | $ | $ | $ | |||
Packaging | |||||||
Total | $ | $ | $ | $ | |||
Nine months ended September 30, 2024 | |||||||
North America | Europe, MEA and APAC | LATAM | Total | ||||
Revenue by product: | |||||||
Paper | $ | $ | $ | $ | |||
Packaging | |||||||
Total | $ | $ | $ | $ | |||
Three months ended September 30, | Nine months ended September 30, | ||||||
2025 | 2024 | 2025 | 2024 | ||||
Impairment charges | $ | $ | $ | $ | |||
Restructuring costs | |||||||
Impairment and restructuring costs | $ | $ | $ | $ | |||
Three months ended September 30, | Nine months ended September 30, | ||||||
2025 | 2024 | 2025 | 2024 | ||||
Impairment of property, plant and equipment | $ | $ | $ | $ | |||
Impairment of other assets | |||||||
Total impairment charges | $ | $ | $ | $ | |||
Three months ended September 30, | Nine months ended September 30, | ||||||
2025 | 2024 | 2025 | 2024 | ||||
North America | $ | $ | $ | $ | |||
Europe, MEA and APAC | |||||||
LATAM | |||||||
Total impairment charges recognized for property, plant and equipment | $ | $ | $ | $ | |||
Three months ended September 30, | Nine months ended September 30, | ||||||
2025 | 2024 | 2025 | 2024 | ||||
North America | $ | $ | $ | $ | |||
Europe, MEA and APAC | |||||||
LATAM | |||||||
Total restructuring costs | $ | $ | $ | $ | |||
Three months ended September 30, | Nine months ended September 30, | ||||||
2025 | 2024 | 2025 | 2024 | ||||
Severance charges | $ | $ | $ | $ | |||
Other costs | |||||||
Total restructuring costs | $ | $ | $ | $ | |||
Severance charges | Other costs | Total | |||
Balance at December 31, 2024 | $ | $ | $ | ||
Charges for the period | |||||
Payments | ( | ( | ( | ||
Balance at September 30, 2025 | $ | $ | $ |
Three months ended September 30, | Nine months ended September 30, | ||||||
2025 | 2024 | 2025 | 2024 | ||||
Transaction-related expenses associated with the Combination | $ | $( | $ | $( | |||
Integration-related expenses associated with the Combination | ( | ( | ( | ( | |||
Total transaction and integration-related expenses associated with the Combination | $( | $( | $( | $( | |||
September 30, | December 31, | ||
2025 | 2024 | ||
Gross accounts receivable | $ | $ | |
Less: Allowances | ( | ( | |
Accounts receivable, net | $ | $ |
September 30, | December 31, | ||
2025 | 2024 | ||
Finished goods | $ | $ | |
Work-in-progress | |||
Raw materials | |||
Consumables and spare parts | |||
Inventories | $ | $ |
September 30, | December 31, | ||
2025 | 2024 | ||
Land and buildings | $ | $ | |
Plant and equipment | |||
Construction-in-progress | |||
Finance lease right-of-use assets | |||
Property, plant and equipment at cost, excluding forestlands | |||
Less: Accumulated depreciation and impairment | ( | ( | |
Property, plant and equipment, net, excluding forestlands | |||
Forestlands, net of depletion | |||
Property, plant and equipment, net | $ | $ |
Three months ended September 30, | Nine months ended September 30, | ||||||
2025 | 2024 | 2025 | 2024 | ||||
Interest expense | $( | $( | $( | $( | |||
Interest income | |||||||
Interest expense, net | $( | $( | $( | $( | |||
September 30, 2025 | December 31, 2024 | ||||||
Book Value | Fair Value | Book Value | Fair Value | ||||
Debt with fixed interest rates | $ | $ | $ | $ | |||
Level 1 | Level 2 | ||||||
September 30, | December 31, | September 30, | December 31, | ||||
2025 | 2024 | 2025 | 2024 | ||||
Assets | |||||||
Other Investments: | |||||||
Listed | $ | $ | $ | $ | |||
Unlisted | |||||||
Derivatives in cash flow hedging relationships | |||||||
Derivatives not designated as hedging instruments | |||||||
Assets measured at fair value | $ | $ | $ | $ | |||
Liabilities | |||||||
Derivatives in cash flow hedging relationships | $ | $ | $ | $ | |||
Derivatives not designated as hedging instruments | |||||||
Liabilities measured at fair value | $ | $ | $ | $ | |||
Nine months ended September 30, | |||
2025 | 2024 | ||
Receivable from financial institutions at January 1 | $ | $ | |
Receivables sold to the financial institutions and derecognized | ( | ( | |
Receivables collected by financial institutions | |||
Cash (payments to) proceeds from financial institutions | ( | ||
Receivable from financial institutions at September 30 | $ | $ | |
September 30, | December 31, | ||
2025 | 2024 | ||
$ | $ | $ | |
$ | |||
$ | |||
€ | |||
$ | |||
$ | |||
€ | |||
€ | |||
€ | |||
$ | |||
$ | |||
$ | |||
$ | |||
$ | |||
$ | |||
€ | |||
€ | |||
$ | |||
$ | |||
$ | |||
€ | |||
$ | |||
$ | |||
$ | |||
Commercial paper | |||
Vendor financing and commercial card programs | |||
Term loan facilities | |||
Bank loans | |||
Finance lease obligations | |||
Bank overdrafts | |||
Total debt, excluding debt issuance costs | |||
Debt issuance costs | ( | ( | |
Total debt | |||
Less: Current portion of debt | ( | ( | |
Non-current debt due after one year | $ | $ |
Defined Benefit Pension Plans | Defined Benefit Pension Plans | ||||||||||||||
U.S. Plans | Non-U.S. Plans | U.S. Plans | Non-U.S. Plans | ||||||||||||
Three months ended September 30, | Nine months ended September 30, | ||||||||||||||
2025 | 2024 | 2025 | 2024 | 2025 | 2024 | 2025 | 2024 | ||||||||
Service cost | $ | $ | $ | $ | $ | $ | $ | $ | |||||||
Interest cost | |||||||||||||||
Expected return on assets | ( | ( | ( | ( | ( | ( | ( | ( | |||||||
Amortization of: | |||||||||||||||
Net actuarial loss | |||||||||||||||
Prior service credit | ( | ( | ( | ||||||||||||
Settlement loss | |||||||||||||||
Net periodic benefit (income) cost | $( | $( | $ | $ | $( | $( | $ | $ | |||||||
Other Postretirement Benefit Plans | Other Postretirement Benefit Plans | ||||||
Three months ended September 30, | Nine months ended September 30, | ||||||
2025 | 2024 | 2025 | 2024 | ||||
Service cost | $ | $ | $ | $ | |||
Interest cost | |||||||
Amortization of: | |||||||
Net actuarial loss | ( | ( | |||||
Net periodic benefit cost | $ | $ | $ | $ | |||
Three months ended September 30, | Nine months ended September 30, | ||||||
2025 | 2024 | 2025 | 2024 | ||||
Numerator: | |||||||
Net income (loss) attributable to common shareholders | $ | $( | $ | $ | |||
Denominator: | |||||||
Basic weighted average shares outstanding | |||||||
Effect of dilutive share options | |||||||
Diluted weighted average shares outstanding | |||||||
Basic earnings (loss) per share attributable to common shareholders | $ | $( | $ | $ | |||
Diluted earnings (loss) per share attributable to common shareholders | $ | $( | $ | $ | |||
Three months ended September 30, | Nine months ended September 30, | ||||||
2025 | 2024 | 2025 | 2024 | ||||
Performance stock units | |||||||
Restricted stock units | |||||||
Total antidilutive shares | |||||||
September 30, | December 31, | ||
2025 | 2024 | ||
Assets | |||
Current assets: | |||
Cash and cash equivalents | $ | $ | |
Accounts receivable | |||
Other current assets | |||
Non-current assets: | |||
Property, plant and equipment, net | |||
Other non-current assets | |||
Total assets | $ | $ | |
Liabilities | |||
Current liabilities: | |||
Accounts payable | $ | $ | |
Current portion of debt | |||
Other current liabilities | |||
Non-current liabilities: | |||
Non-current debt due after one year | |||
Other non-current liabilities | |||
Total liabilities | $ | $ |
Foreign Currency Translation | Cash Flow Hedges | Defined Benefit Pension and Other Postretirement Benefit Plans | Other Reserves(1) | Total(2) | |
Balance at June 30, 2024 | $ | $ | $ | $( | $ |
Other comprehensive (income) loss | ( | ( | |||
Balance at September 30, 2024 | $ | $ | $ | $( | $ |
Balance at June 30, 2025 | $ | $ | $ | $( | $ |
Other comprehensive income | ( | ( | ( | ( | |
Balance at September 30, 2025 | $ | $ | $ | $( | $ |
Foreign Currency Translation | Cash Flow Hedges | Defined Benefit Pension and Other Postretirement Benefit Plans | Other Reserves(1) | Total(2) | |
Balance at December 31, 2023 | $ | $ | $ | $( | $ |
Other comprehensive loss (income) | ( | ( | |||
Balance at September 30, 2024 | $ | $ | $ | $( | $ |
Balance at December 31, 2024 | $ | $ | $ | $( | $ |
Other comprehensive (income) loss | ( | ( | |||
Balance at September 30, 2025 | $ | $ | $ | $( | $ |
Three months ended September 30, | |||||||
2025 | 2024 | ||||||
Pre-Tax | Tax | Net of Tax | Pre-Tax | Tax | Net of Tax | ||
Foreign currency translation gain | $ | $ | $ | $ | $ | $ | |
Defined benefit pension and other postretirement benefit plans: | |||||||
Amortization and settlement recognition of net actuarial loss | ( | ( | |||||
Amortization of prior service credit | ( | ( | |||||
Foreign currency gain (loss) - pensions | ( | ( | |||||
Changes in fair value of cash flow hedges | |||||||
Consolidated other comprehensive income | ( | ( | |||||
Other comprehensive income attributable to noncontrolling interests | |||||||
Other comprehensive income attributable to common shareholders | $ | $( | $ | $ | $( | $ | |
Nine months ended September 30, | |||||||
2025 | 2024 | ||||||
Pre-Tax | Tax | Net of Tax | Pre-Tax | Tax | Net of Tax | ||
Foreign currency translation gain (loss) | $ | $ | $ | $( | $ | $( | |
Defined benefit pension and other postretirement benefit plans: | |||||||
Net actuarial loss arising during period | ( | ( | ( | ( | |||
Amortization and settlement recognition of net actuarial loss | ( | ( | |||||
Prior service cost arising during period | ( | ( | |||||
Amortization of prior service credit | ( | ( | ( | ( | |||
Foreign currency loss - pensions | ( | ( | ( | ( | |||
Changes in fair value of cash flow hedges | ( | ( | |||||
Consolidated other comprehensive income (loss) | ( | ( | ( | ||||
Other comprehensive income attributable to noncontrolling interests | |||||||
Other comprehensive income (loss) attributable to common shareholders | $ | $ | $ | $( | $( | $( | |
Three months ended September 30, | Nine months ended September 30, | ||||||
2025 | 2024 | 2025 | 2024 | ||||
Net sales | $8,003 | $7,671 | $23,599 | $13,570 | |||
Cost of goods sold | (6,434) | (6,321) | (18,938) | (10,817) | |||
Gross profit | 1,569 | 1,350 | 4,661 | 2,753 | |||
Selling, general and administrative expenses | (963) | (1,007) | (2,899) | (1,776) | |||
Impairment and restructuring costs | (65) | (21) | (360) | (21) | |||
Transaction and integration-related expenses associated with the Combination | (15) | (267) | (72) | (350) | |||
Operating profit | 526 | 55 | 1,330 | 606 | |||
Pension and other postretirement non-service income (expense), net | 8 | 8 | 24 | (31) | |||
Interest expense, net | (177) | (167) | (526) | (225) | |||
Other expense, net | (21) | (13) | (44) | (13) | |||
Income (loss) before income taxes | 336 | (117) | 784 | 337 | |||
Income tax expense | (91) | (33) | (183) | (164) | |||
Net income (loss) | 245 | (150) | 601 | 173 | |||
Net loss attributable to noncontrolling interests | 1 | — | 1 | — | |||
Net income (loss) attributable to common shareholders | $246 | $(150) | $602 | $173 | |||
Three months ended September 30, | Nine months ended September 30, | ||||||
2025 | 2024 | 2025 | 2024 | ||||
Net sales (aggregate):(1) | |||||||
North America | $4,721 | $4,649 | $14,145 | $5,499 | |||
Europe, MEA and APAC | 2,831 | 2,651 | 8,191 | 7,056 | |||
LATAM | 545 | 506 | 1,576 | 1,187 | |||
Segment Adjusted EBITDA: | |||||||
North America | $810 | $780 | $2,347 | $900 | |||
Europe, MEA and APAC | 419 | 411 | 1,180 | 1,158 | |||
LATAM | 116 | 116 | 354 | 257 | |||
Nine months ended September 30, | |||
2025 | 2024 | ||
Net cash provided by operating activities | $2,197 | $702 | |
Net cash used for investing activities | $(1,564) | $(1,595) | |
Net cash (used for) provided by financing activities | $(674) | $869 | |
Three months ended September 30, | Nine months ended September 30, | ||||||
2025 | 2024 | 2025 | 2024 | ||||
Net income (loss) | $245 | $(150) | $601 | $173 | |||
Income tax expense | 91 | 33 | 183 | 164 | |||
Depreciation, depletion and amortization | 659 | 564 | 1,875 | 872 | |||
Impairment and restructuring costs | 65 | 21 | 360 | 21 | |||
Transaction and integration-related expenses associated with the Combination | 15 | 267 | 72 | 350 | |||
Amortization of fair value step up on inventory | — | 227 | — | 227 | |||
Interest expense, net | 177 | 167 | 526 | 225 | |||
Pension and other postretirement non-service (income) expense, net | (8) | (8) | (24) | 31 | |||
Share-based compensation expense | 35 | 123 | 114 | 154 | |||
Other expense, net | 21 | 13 | 44 | 13 | |||
Other adjustments | 2 | 8 | 16 | (10) | |||
Adjusted EBITDA | $1,302 | $1,265 | $3,767 | $2,220 | |||
SUMMARIZED STATEMENT OF OPERATIONS | Nine months ended September 30, |
2025 | |
Net sales to unrelated parties | $1,100 |
Net sales to Non-Obligor Subsidiaries | 909 |
Gross profit | 697 |
Interest expense, net with unrelated parties | (464) |
Interest expense, net with Non-Obligor Subsidiaries | (253) |
Net income and net income attributable to the Obligor Group | 291 |
SUMMARIZED BALANCE SHEETS | September 30, | December 31, | |
2025 | 2024 | ||
ASSETS | |||
Current amounts due from Non-Obligor Subsidiaries | $5,617 | $4,925 | |
Other current assets | 920 | 1,049 | |
Total current assets | $6,537 | $5,974 | |
Non-current amounts due from Non-Obligor Subsidiaries | $2,938 | $2,848 | |
Other non-current assets | 384 | 370 | |
Total non-current assets | $3,322 | $3,218 | |
LIABILITIES | |||
Current amounts due to Non-Obligor Subsidiaries | $8,320 | $9,681 | |
Other current liabilities | 999 | 1,122 | |
Total current liabilities | $9,319 | $10,803 | |
Non-current amounts due to Non-Obligor Subsidiaries | $6,467 | $6,604 | |
Other non-current liabilities | 11,683 | 9,644 | |
Total non-current liabilities | $18,150 | $16,248 |
Period | Total Number of Shares Purchased(1) | Average Price Paid per Share | Total Number of Shares Purchased as Part of Publicly Announced Programs | Approximate Dollar Value of Shares that May Yet Be Purchased Under the Programs | |||
July 1, 2025 – July 31, 2025 | 822 | $43.00 | — | — | |||
August 1, 2025 – August 31, 2025 | — | — | — | — | |||
September 1, 2025 – September 30, 2025 | — | — | — | — | |||
Total | 822 | — |
Exhibit Number | Description of Exhibit | ||
3.1 | Amended Constitution of Smurfit Westrock plc (incorporated by reference to Exhibit 3.1 of the Company’s Current Report on Form 8-K filed on July 8, 2024). | ||
10.1†+ | Second Amendment to Purchasing and Servicing of Receivables, dated as of September 12, 2025, among WestRock Company, various WestRock Company subsidiaries, and Coöperatieve Rabobank, U.A. | ||
22 | List of Guarantor Subsidiaries and Issuers of Guaranteed Securities (incorporated by reference to Exhibit 22 of the Company’s Quarterly Report on Form 10-Q filed on August 7, 2025). | ||
31.1† | Certification of the Principal Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | ||
31.2† | Certification of the Principal Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | ||
32†* | Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | ||
101.INS | Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.** | ||
101.SCH | Inline XBRL Taxonomy Extension Schema.** | ||
101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase.** | ||
101.DEF | Inline XBRL Taxonomy Extension Definition Document.** | ||
101.LAB | Inline XBRL Taxonomy Extension Label Linkbase.** | ||
101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase.** | ||
104 | Cover Page Interactive Data File––the cover page interactive data file does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. |
Smurfit Westrock plc | ||
Dated: November 7, 2025 | /s/ Anthony Smurfit | |
Name: | Anthony Smurfit | |
Title: | President & Group Chief Executive Officer | |
(Principal Executive Officer) | ||
Smurfit Westrock plc | ||
Dated: November 7, 2025 | /s/ Ken Bowles | |
Name: | Ken Bowles | |
Title: | Executive Vice President & Group Chief Financial Officer | |
(Principal Financial Officer) | ||